Search results
Moderna Inc. (MRNA) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoAt this time, I'd like to turn the call over to Lavina Talukdar, head of investor relations at Moderna. Good morning, everyone, and thank you for joining...
Moderna exec says COVID trials improved diversity recruiting
Reuters via Yahoo News· 2 years agoModerna Inc's top scientist said on Tuesday that the vaccine maker has learned how to better recruit...
Moderna’s Chief Medical Officer explains importance of variant-specific booster shot
WFXT via Yahoo News· 2 years agoDownload the FREE Boston 25 News app for breaking news alerts. Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW
This week in COVID: Moderna sues Pfizer-BioNTech, Paxlovid study shows no benefit for certain...
USA TODAY via Yahoo News· 2 years agoModerna is suing fellow vaccine developers Pfizer and German partner BioNTech for infringing on...
Moderna’s ‘next generation’ COVID booster approved for use in U.K.
Fortune via Yahoo Finance· 2 years agoModerna’s “next generation” COVID booster, which targets both the original and Omicron strains of...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 1 week agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna commercial officer steps down, CEO to look over vaccine sales
Reuters via Yahoo Finance· 6 months agoHer exit from the role comes at a time when the company, which is looking to break even in 2026, is...
Moderna's mRNA-Based RSV Vaccine Just Passed a Major Test
Time via Yahoo News· 1 year agoCredit - Getty Images/Cavan Images RF Moderna has become a well-known name thanks to its highly...
Moderna exec: 'eager' to collaborate with China on supplying COVID vaccines
Reuters via Yahoo Finance· 2 years agoTOKYO, Sept 21 (Reuters) - Moderna Inc Chief Medical Officer Paul Burton said on Wednesday the company is "eager" to collaborate with China on supplying its mRNA-based COVID-19 vaccines to the ...
Moderna says flu shot misses early success bar, but expects 2024 revenue
Reuters via Yahoo News· 1 year agoBOSTON (Reuters) -Moderna Inc said on Tuesday its experimental flu vaccine did not meet the criteria...